Failure to Ensure Accurate and Timely Medication Administration for Antihypertensives and Anticoagulant
Summary
The deficiency involves the facility’s failure to ensure residents were free from significant medication errors and to follow its own medication administration policies, particularly regarding timeliness, accuracy of orders, and documentation. One resident (R3), who has diagnoses including heart failure, hypertensive heart disease, type 2 diabetes mellitus, end stage renal disease with dependence on dialysis, and obesity, and who is cognitively intact with a BIMS score of 14, reported frequently receiving medications late and stated that on the day of observation the resident had not received any medications despite returning from dialysis at 10:30 AM. At 12:17 PM, an RN (V18) assessed R3’s blood pressure at 147/89 with a heart rate of 100 and acknowledged to the resident that the blood pressure was high because medications were being given late, specifically referencing the resident’s beta blocker and hypertension medications. At approximately 12:24 PM, V18 prepared R3’s morning medications, including nifedipine ER 60 mg, metoprolol tartrate 12.5 mg, gabapentin 100 mg, sevelamer 800 mg, and calcitriol 0.5 mcg, and stated these medications should have been given around 9:00 AM but were late. At 12:30 PM, V18 administered the medications to R3 and told the resident that medications were not supposed to be given outside the one-hour before/after window, describing this as a legal requirement, but proceeded with administration due to the elevated blood pressure. V18 further explained that the facility’s procedure is to check vital signs and then administer medications, and admitted that R3’s medications should have been given as soon as possible after returning from dialysis at 10:30 AM. V18 stated that the medications were not given timely because the nurse was responsible for 27–30 residents and acknowledged having given R3’s medications late on prior occasions, describing it as difficult to complete medication passes on time. The consultant pharmacist (V16) confirmed that nifedipine and metoprolol were being used to treat blood pressure and stated that if these medications are not received, blood pressure is expected to increase, emphasizing that nifedipine ER should be given at the same time every day. Upon reviewing R3’s record, V16 found no documentation of when the previous evening’s metoprolol dose was given and could not determine whether it had been administered, noting that nurses should document all administrations or refusals. The DON (V2) confirmed that facility policy allows a one-hour before and after window for medication administration and that medications for residents on dialysis should be scheduled so they can be administered at the same time every day, with nurses expected to notify the provider if scheduled times conflict with dialysis. V2 verified that R3’s nifedipine and metoprolol were scheduled for 9:00 AM, during dialysis chair time, and that R3 had not been consistently receiving these medications at the ordered times. V2 stated that V18 could have administered the medications closer to the scheduled time and confirmed there was no documentation that the 6:00 PM metoprolol dose was given on 4/12/2026. Review of R3’s Medication Administration Audit Report showed multiple late administrations of metoprolol and nifedipine on various dates, as well as missing documentation for certain metoprolol doses. R3’s progress notes contained only one entry indicating the resident requested morning medications after dialysis, with no further documentation explaining late administrations or provider notification about late or missed doses. These practices conflicted with facility policies requiring medications to be administered within 60 minutes of the scheduled time, accurate documentation of administration or refusal, and explanatory notes when doses are withheld, refused, or given at times other than scheduled. A second resident (R2), admitted with diagnoses including type 2 diabetes, hypertension, schizophrenia, atrial fibrillation, chronic right heart failure, and a left below-knee amputation, and cognitively intact with a BIMS score of 13, reported that nurses had R2’s medication doses and times wrong and that medications were often passed late or not given at all. Hospital discharge documentation for R2 listed Eliquis 5 mg to be taken orally twice daily, but R2’s March MAR showed an order for Eliquis 5 mg once daily starting shortly after admission, and R2 received the medication only once daily for eight days. The MAR later reflected a corrected order for Eliquis 5 mg twice daily. A progress note documented that pharmacy contacted the facility on 3/10/26 stating Eliquis is always given twice daily and that the MD needed to correct the order; the nurse noted reaching out to the provider but receiving no response at that time. The consultant pharmacist confirmed that Eliquis is never given once daily, that manufacturer recommendations are for twice-daily dosing, and that once-daily dosing for atrial fibrillation management could lead to irregular heart rate or increased risk for clots. The DON stated that the admitting nurse entered the Eliquis order incorrectly, that Eliquis is supposed to be given BID, and that R2 received the wrong Eliquis dose for a few days. Facility policies titled “Guidelines For Physician Orders (Following Physician Orders)” and “Section 5.0 Medication Administration” require that physician orders be accurately implemented and followed, that two nurses review admission and readmission orders as a double check, and that medications be administered as prescribed and within 60 minutes of the scheduled time. These policies also require that unusual doses or orders that appear inconsistent with a resident’s diagnosis be clarified with the physician prior to administration, that the MAR be initialed for each dose given, and that any withheld, refused, or off-schedule doses be circled and explained in the record, with physician notification if two consecutive doses are withheld or refused. The observed late, inconsistent, and undocumented administration of antihypertensive medications for R3, the lack of timely rescheduling or provider notification related to dialysis conflicts, and the incorrect once-daily Eliquis order and administration for R2, despite pharmacy input and existing policies, collectively demonstrate the facility’s failure to ensure residents were free from significant medication errors and to adhere to its own medication administration procedures.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Significant morphine dose error: An RN administered 0.25 mL (5 mg) of morphine sulfate buccally instead of the ordered 0.1 mL (2 mg) dose to a resident with severe cognitive impairment, Alzheimer’s disease, CAD, and dementia. The RN said she followed the medication box label, while the unit manager confirmed the correct dose was on the EMAR. The resident was assessed afterward and remained unchanged.
An LPN administered Humalog insulin to a resident with stroke, aphasia, and diabetes without priming the insulin pen as required by manufacturer instructions. The LPN dialed the ordered 5-unit dose but did not prime the pen with 2 units before injection, and later stated she was unaware of the need to prime it. The DON confirmed insulin pens should be primed according to the manufacturer's instructions.
A resident with CHF and dysphagia had a medication error when an MA crushed and administered multiple morning meds, including Potassium Chloride ER, despite a provider order that it not be crushed. The facility policy required meds to be given as ordered and prohibited crushing do-not-crush, slow-release, and enteric-coated meds; the record also identified potassium chloride as a high-alert medication.
Two residents experienced significant medication errors when ordered meds were not available or not administered as prescribed. One resident on hospice went more than 24 hours after admission without ordered Morphine for pain and air hunger, while another resident missed multiple doses of a Lidocaine patch and Mirabegron because the meds were out of stock or not obtained from the pharmacy, with the DON confirming the missed doses and unrelieved pain were significant.
A resident with moderately impaired cognition and cerebral amyloid angiopathy had a weekly buprenorphine patch order inaccurately transcribed as Suboxone on the MAR. Staff also applied a new pain patch without removing the old one, leaving two active patches on the resident for several days. The DON stated the admission verification process was not followed and the incident was not investigated.
A resident with DM2 and multiple chronic conditions had an order for daily insulin glargine, but an RN documented that the dose was not given because the medication was unavailable. An LPN stated staff should reorder meds when five doses remain and, if out, notify the provider and pharmacy and use the emergency medication supply system; an RN and the DON confirmed backup insulin was available in a lockbox, and the DON noted there was no documentation explaining the omission.
Significant morphine dose error
Penalty
Summary
The facility failed to ensure a resident was free from a significant medication error when an RN administered 5 mg of morphine sulfate instead of the prescribed 2 mg dose. The resident had severe cognitive impairment and diagnoses that included Alzheimer's disease, coronary artery disease, and dementia. The physician orders directed morphine sulfate concentrate oral solution 100 mg/5 mL to be given as 2 mg (0.1 mL) buccally every four hours for pain, with a separate PRN order for 5 mg (0.25 mL) buccally every hour as needed for breakthrough pain or shortness of breath. The EMAR showed the resident received the scheduled 2 mg dose at 4:00 p.m. and did not show a PRN 5 mg dose. During observation, RN-B withdrew 0.25 mL of morphine sulfate using the syringe provided with the medication and administered it buccally to the resident, then documented on the narcotic record book that 0.1 mL had been given. RN-B stated she gave 0.25 mL because the medication box label identified 0.25 mL, while RN-A stated the correct dose was 0.1 mL and acknowledged the error after RN-B confirmed the amount administered. The resident was assessed after the error and remained unchanged, with vital signs and condition stable. The DON stated the medication label had been followed instead of the EMAR, and the consultant pharmacist stated the resident could have experienced increased drowsiness from the error.
Insulin Pen Not Primed Before Administration
Penalty
Summary
The facility failed to ensure residents were free from significant medication errors when it did not follow insulin pen preparation instructions for Resident #8. Resident #8 was admitted with multiple diagnoses including cerebral infarction (stroke), aphasia, and diabetes, and had a physician order for Humalog (Lispro) insulin pen-injector 100 units/ml to be injected subcutaneously at 5 units before meals for type 2 diabetes. During observation on 8/4/26, an LPN removed the Humalog insulin pen from the medication cart and dialed it to the ordered 5 units, but did not prime the pen with 2 units before administering the dose. The insulin was then given to Resident #8. When interviewed shortly afterward, the LPN stated she did not prime the insulin pen and was unaware of the need to do so before administering insulin. The DON stated insulin pens should be primed according to the manufacturer's instructions and had not been.
Significant medication error involving crushing a do-not-crush ER medication
Penalty
Summary
The facility failed to ensure that a resident was free from significant medication errors when a Medication Aide crushed and administered medications that included Potassium Chloride ER, despite a physician order stating the medication was to be given by mouth twice daily and not crushed. The resident had diagnoses of chronic diastolic heart failure and dysphagia following a cerebral infarction, and the physician’s orders contained no instruction to crush medications. The facility policy stated medications should be administered as ordered and that medications with do-not-crush instructions, including slow release and enteric coated medications, should not be crushed. During observation, the Medication Aide confirmed they were going to crush all of the resident’s morning medications except Pantoprazole. The aide then placed Clopidogrel, Potassium Chloride ER, Sertraline, and Torsemide into a medication cup, crushed them, added pudding, and fed the mixture to the resident. The record review also identified Potassium Chloride as a high alert medication and cited guidance stating that enteric-coated or extended-release tablets or capsules should not be chewed or crushed.
Significant medication errors from delayed and missed ordered medications
Penalty
Summary
The facility failed to obtain physician-ordered medications in a timely manner, resulting in significant medication errors for two residents. One resident was admitted to the facility on 7/9/26 under hospice care with end-stage heart failure and had an order for Morphine Sulfate concentrate 10 mg sublingually every hour as needed for pain and/or air hunger. The resident did not receive Morphine on the day of admission, and the first documented dose was not given until 7/10/26 at 1:41 p.m., about 26 hours after admission. The MAR documented 26 potential missed PRN doses, and the resident’s family member and an LPN stated the medication was not available when needed and that the resident had signs of pain during that period. A second resident had orders for a Lidocaine external patch once daily for mild pain and Mirabegron ER 25 mg daily for urinary antispasmodic use. The MAR and nursing notes documented that the Lidocaine patch was not administered for multiple days because it was out of stock, with missed applications documented on 7/26, 7/27, 7/29, and 7/30, and 7/28 signed in error as given. The resident stated the missed patches prevented comfortable sleep. The same resident also missed Mirabegron doses on multiple days because the medication was on order from the pharmacy and not available, with documentation showing missed administration on 7/14, 7/15, 7/16, 7/17, 7/19, 7/20, and 7/21, and one date documented as given in error. The DON confirmed the Lidocaine order did not include a dose and acknowledged the resident missed several doses because the facility ran out of the patches. The DON also confirmed the Mirabegron was not supplied as expected and that the convenience box did not contain that medication. The resident and family member stated the missed medications affected pain control, sleep, and urinary urgency, and the DON stated the quantity of missed doses and unrelieved pain equated to significant medication errors.
Medication Order Transcription Error and Duplicate Pain Patch Application
Penalty
Summary
The facility failed to ensure a resident remained free from significant medication errors when admission medication orders were not accurately transcribed to the MAR. The resident was admitted with diagnoses including cerebral amyloid angiopathy, and the comprehensive assessment showed moderately impaired cognition and a need for assistance from one staff member with ADLs. The hospital discharge orders included a weekly buprenorphine transdermal patch, but the July 2026 MAR listed the medication as a weekly Suboxone transdermal patch instead. Staff later stated the wrong medication name was entered because Suboxone was believed to be the same medication as buprenorphine, and the admission body check was not completed to determine whether a transdermal patch was already present. The resident representative reported that facility staff applied a new pain patch without removing the old one, leaving two active patches on the resident for three days. Staff later confirmed one patch was on the right shoulder and another on the left shoulder, and the older patch was then removed. The DON stated the facility’s medication error process included staff interviews, physician notification, alert charting, and monitoring for high-alert medications, but also stated the incident was not investigated and no medication error report was completed. The DON further stated the admission process required a three-step verification of orders, and that process was not followed for this resident.
Missed Insulin Dose Due to Medication Unavailability
Penalty
Summary
A resident with type 2 diabetes mellitus, chronic diastolic heart failure, chronic respiratory failure, and obesity had a physician order for Insulin Glargine Solostar 300 units/mL, 50 units subcutaneously once daily. On 3/20/26 at 11:19 AM, an RN documented that the insulin was not administered because the medication was unavailable. During interviews on 7/30/26, an LPN stated that medications should be reordered through the eMAR when five doses remain and that if a medication is completely out, staff must immediately notify the provider and pharmacy and use the emergency medication supply system. An RN confirmed that backup insulin was available in a lockbox in the third-floor refrigerator and that staff should not run out of insulin. The DON also confirmed the backup insulin location and the pharmacy restocking alert system, and stated there was no documentation in the progress notes or TAR explaining the omission; because she was not employed at the facility at the time, the exact reason for the unavailable medication and omitted dose remained unknown.
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release October 8, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.